Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 54, 2019 - Issue 9
Submit an article Journal homepage
335
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Lupus-like reactions in patients with inflammatory bowel disease treated with anti-TNFs are insidious adverse events: data from a large single-center cohort

Fabio Salvatore MacalusoInflammatory Bowel Disease Unit, A.O.O.R. “Villa Sofia-Cervello”, Palermo, ItalyCorrespondence[email protected]
,
Chiara SapienzaInflammatory Bowel Disease Unit, A.O.O.R. “Villa Sofia-Cervello”, Palermo, Italy
,
Marco VentimigliaInflammatory Bowel Disease Unit, A.O.O.R. “Villa Sofia-Cervello”, Palermo, Italy
,
Sara RennaInflammatory Bowel Disease Unit, A.O.O.R. “Villa Sofia-Cervello”, Palermo, Italy
,
Mario CottoneInflammatory Bowel Disease Unit, A.O.O.R. “Villa Sofia-Cervello”, Palermo, Italy
&
Ambrogio OrlandoInflammatory Bowel Disease Unit, A.O.O.R. “Villa Sofia-Cervello”, Palermo, Italy
Pages 1102-1106 | Received 29 Jun 2019, Accepted 28 Aug 2019, Published online: 06 Sep 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Daniella Pigniczki, Mariann Rutka, Klaudia Farkas & Tamas Molnar. (2019) Lupus-like reactions in patients with inflammatory bowel disease: a little bit different data from another center. Scandinavian Journal of Gastroenterology 54:12, pages 1498-1498.
Read now

Articles from other publishers (10)

Ofelia Baniandrés-Rodríguez & Cristina Ciudad-Blanco. (2024) Reacciones cutáneas (no paradójicas) inducidas por tratamientos biológicos. Piel.
Crossref
Minnie Au, Georgina Heddle, Edward Young, Emma Ryan, Scott Graf, Derrick Tee & Hamish Philpott. (2022) Anti‐tumour necrosis factor‐induced skin rashes in inflammatory bowel disease: a systematic review and evidence‐based management algorithm. Internal Medicine Journal 53:10, pages 1854-1865.
Crossref
Shubha Bhat, Benjamin Click & Miguel Regueiro. (2023) Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies. Inflammatory Bowel Diseases.
Crossref
Cong Dai, Yi-nuo Wang, Wen-ning Tian, Yu-Hong Huang & Min Jiang. (2022) The incidence, clinical characteristics and serological characteristics of anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: A systematic review and meta-analysis. International Immunopharmacology 112, pages 109269.
Crossref
Michael J. Murphy, Jeffrey M. Cohen, Matthew D. Vesely & William Damsky. (2022) Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysis. Journal of the American Academy of Dermatology 86:5, pages 1080-1091.
Crossref
Eirini Theodoraki, Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Nikolaos-Panagiotis Andreou, Maria Gazouli & Ioannis E. Koutroubakis. (2022) Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with inflammatory bowel disease. International Journal of Colorectal Disease 37:3, pages 639-646.
Crossref
María José García, Juan Carlos Rodríguez-Duque, Marta Pascual, Coral Rivas, Beatriz Castro, Sandra Raso, Marcos López-Hoyos, María Teresa Arias-Loste & Montserrat Rivero. (2022) Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy. Therapeutic Advances in Gastroenterology 15, pages 175628482210778.
Crossref
Su Jin Choi, Soo Min Ahn, Ji Seon Oh, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park & Yong-Gil Kim. (2021) Anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: a hospital-based cohort study from Korea. Therapeutic Advances in Gastroenterology 14, pages 175628482199779.
Crossref
Anna Lyakhovitsky, Karin Warshavsky, Lihi Rozner, Theodoulos Drousiotis, Sharon Baum & Aviv Barzilai. (2020) Dermatomyositis–lupuslike syndrome overlap under treatment with etanercept for rheumatoid arthritis. JAAD Case Reports 6:8, pages 758-760.
Crossref
. (2019) Adalimumab/infliximab. Reactions Weekly 1781:1, pages 20-20.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.